Associations of Tumor Necrosis Factor-Alpha Gene Polymorphisms

TNF-α-2 age-related macular degeneration (AMD)-1 rs1800629-4 rs18006303-3 rs361525-5

Journal

Life (Basel, Switzerland)
ISSN: 2075-1729
Titre abrégé: Life (Basel)
Pays: Switzerland
ID NLM: 101580444

Informations de publication

Date de publication:
21 Jun 2022
Historique:
received: 30 05 2022
revised: 17 06 2022
accepted: 19 06 2022
entrez: 27 7 2022
pubmed: 28 7 2022
medline: 28 7 2022
Statut: epublish

Résumé

Age-related macular degeneration (AMD) is a neurodegenerative disease leading to irreversible central vision loss among the elderly in developed countries. While the disease accounts for 9% of all cases of vision loss, the prevalence of AMD is likely to increase due to the exponential aging of the population. Due to this reason, our study aimed to determine the associations of tumor necrosis factor-alpha (TNF-α) gene single-nucleotide polymorphisms (SNPs) TNF-863A/C (rs1800630), TNF-308A/G (rs1800629), TNF-238A/G (rs361525), and TNF-α serum concentration with age-related macular degeneration. Analysis of TNF-α rs1800630, rs1800629, and rs361525 polymorphisms showed that the TNF-α rs1800630 A allele was statistically significantly more frequent in the exudative AMD group compared to the control group (p = 0.029). Additionally, the TNF-α rs1800630 A allele was more frequent in females with exudative AMD than in the control group of healthy females (p = 0.027). The TNF-α rs1800630 A allele was more frequent in females with exudative AMD than in females with early AMD (p = 0.014). TNF-α rs1800630, rs1800629, and rs361525 haplotype A-A-G were associated with decreased odds of exudative AMD (p < 0.0001), and haplotype A-G-G was associated with 24-fold increased exudative AMD occurrence (p < 0.0001). TNF-α protein levels were lower in subjects with exudative AMD compared to the control group (p < 0.001). The study showed significant associations between inflammatory cytokine TNF-α single-nucleotide polymorphisms and serum level with AMD pathogenesis. Analysis of TNF-α genotypes and serum concentration may be helpful for the AMD diagnosis.

Identifiants

pubmed: 35888018
pii: life12070928
doi: 10.3390/life12070928
pmc: PMC9319996
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Ophthalmology. 2002 Apr;109(4):730-6
pubmed: 11927430
J Ophthalmic Vis Res. 2012 Jan;7(1):39-44
pubmed: 22737386
Biochim Biophys Acta. 2015 Feb;1850(2):435-46
pubmed: 25450174
Int J Obes Relat Metab Disord. 2000 Nov;24(11):1392-5
pubmed: 11126333
BMC Ophthalmol. 2019 Apr 24;19(1):94
pubmed: 31014258
Eur Cytokine Netw. 2012 Oct-Dec;23(4):163-5
pubmed: 23328497
Prog Retin Eye Res. 2009 Jan;28(1):1-18
pubmed: 19026761
Clin Genet. 2013 Aug;84(2):160-6
pubmed: 23713713
Schizophr Res. 2015 Dec;169(1-3):10-15
pubmed: 26589393
Clin Interv Aging. 2017 Aug 22;12:1313-1330
pubmed: 28860733
Clin Ophthalmol. 2016 Jul 04;10:1229-35
pubmed: 27445455
Genes Genomics. 2020 Jul;42(7):743-750
pubmed: 32445180
Adv Exp Med Biol. 2021;1256:191-200
pubmed: 33848002
Springerplus. 2016 Sep 07;5(1):1508
pubmed: 27652081
Ophthalmology. 2001 Apr;108(4):697-704
pubmed: 11297486
Community Eye Health. 2014;27(87):49-50
pubmed: 25918464
Am J Ophthalmol. 2001 Nov;132(5):668-81
pubmed: 11704028
Clin Interv Aging. 2017 Oct 03;12:1579-1587
pubmed: 29042759
Oncotarget. 2017 Nov 30;8(67):111456-111469
pubmed: 29340067
Indian J Dermatol. 2015 Jul-Aug;60(4):345-50
pubmed: 26286396
J Cell Physiol. 2012 Jan;227(1):116-26
pubmed: 21374591
Dtsch Arztebl Int. 2020 Jul 20;117(29-30):513-520
pubmed: 33087239
Sci Rep. 2016 Sep 06;6:32677
pubmed: 27597177
Int J Ophthalmol. 2019 Jan 18;12(1):25-29
pubmed: 30662836
Hum Mol Genet. 2017 Aug 1;26(R1):R45-R50
pubmed: 28854576
Lancet Glob Health. 2014 Feb;2(2):e106-16
pubmed: 25104651
Semin Ophthalmol. 2011 May;26(3):77-93
pubmed: 21609220
Front Physiol. 2018 May 15;9:469
pubmed: 29867530
Crit Rev Eukaryot Gene Expr. 2010;20(2):87-103
pubmed: 21133840
Front Aging Neurosci. 2014 Jul 10;6:151
pubmed: 25071560
Medicina (Kaunas). 2016;52(2):79-88
pubmed: 27170480
J Ophthalmol. 2014;2014:582842
pubmed: 25478207
Immunol Invest. 2022 May;51(4):859-882
pubmed: 33557638
J Periodontal Res. 2021 Apr;56(2):226-235
pubmed: 33368258

Auteurs

Guoda Zazeckyte (G)

Medical Academy, Lithuanian University of Health Sciences, Eiveniu Str. 2, LT-50161 Kaunas, Lithuania.

Greta Gedvilaite (G)

Neuroscience Institute, Medical Academy, Lithuanian University of Health Sciences, Eiveniu Str. 2, LT-50161 Kaunas, Lithuania.

Alvita Vilkeviciute (A)

Neuroscience Institute, Medical Academy, Lithuanian University of Health Sciences, Eiveniu Str. 2, LT-50161 Kaunas, Lithuania.

Loresa Kriauciuniene (L)

Neuroscience Institute, Medical Academy, Lithuanian University of Health Sciences, Eiveniu Str. 2, LT-50161 Kaunas, Lithuania.

Vilma Jurate Balciuniene (VJ)

Department of Ophthalmology, Medical Academy, Lithuanian University of Health Sciences, Eiveniu Str. 2, LT-50161 Kaunas, Lithuania.

Ruta Mockute (R)

Medical Academy, Lithuanian University of Health Sciences, Eiveniu Str. 2, LT-50161 Kaunas, Lithuania.

Rasa Liutkeviciene (R)

Neuroscience Institute, Medical Academy, Lithuanian University of Health Sciences, Eiveniu Str. 2, LT-50161 Kaunas, Lithuania.

Classifications MeSH